- cross-posted to:
- technology@lemmy.ml
- cross-posted to:
- technology@lemmy.ml
machine learning algorithm designs antibodies to target specific diseases, then automated robotic systems build and grow them in lab, run tests, and feed data back into algorithm, all with limited human supervision.
doesn’t change the fact that this will probably be affordable only by people with deep pockets
Or everybody outside of the states
If you meant “everybody on Europe” I’d reluctantly agree. But almost no one in Africa, or South America, or most of Asia will have access to this too
You might be surprised how prevalent universal healthcare is in Asia. Source, am Asian.
That aside, my point was largely to poke holes in the US-centric viewpoint that seems to be the default online.
Russia, India and Bangladesh are on Asia too. Plenty of poor countries on Asia. But, this is a second-handed account since I’m not from Asia, I’m from South America
I understand. They really tend to see themselves as the default, despite being fewer than 4% of the world in absolute numbers, it is unnerving sometimes